Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795052 · ClinicalTrials.gov registry record · NA
Neurologic Stem Cell Treatment Study
A NA study of Stroke and Traumatic Brain Injury, sponsored by MD Stem Cells.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 3
- Study locations
NCT02795052 is a NA study of Stroke and Traumatic Brain Injury that is actively recruiting participants, run by MD Stem Cells. The registered enrollment target is 500 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT02795052, a NA study of Stroke and Traumatic Brain Injury, is actively recruiting participants, sponsored by MD Stem Cells.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/
Conditions Studied
Interventions
- PROCEDURE Intravenous and Intranasal BMSC
Study Locations (3)
Connecticut
- MD Stem Cells - Westport
Florida
- MD Stem Cells - Coral Springs
Other
- The Saudi-German Hospital - Dubai
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2016-06 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02795052
The ClinicalTrials.gov registry entry for NCT02795052 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The listed sponsor is MD Stem Cells, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Intravenous and Intranasal BMSC is the first listed.
NCT02795052 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Florida, Other.
Frequently Asked Questions
What is clinical trial NCT02795052 about?
NCT02795052 is a clinical study titled "Neurologic Stem Cell Treatment Study". This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain ne...
What is the current status of trial NCT02795052?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2016-06. Estimated completion is 2027-07-31.
What conditions does trial NCT02795052 study?
This clinical trial studies the following conditions: Stroke, Traumatic Brain Injury, Nervous System Diseases, Neurodegenerative Diseases, Neurologic Disorders.
What interventions are being tested in trial NCT02795052?
The interventions under investigation include: Intravenous and Intranasal BMSC (PROCEDURE).
Who is sponsoring clinical trial NCT02795052?
This trial is sponsored by MD Stem Cells, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02795052 being conducted?
This trial has 3 study locations across Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.